Mutations in BMPR2 result in pulmonary Hypertension (PAH), a vascular disorder characterized by uncontrolled remodeling of the pulmonary arteries due to increased proliferation of VSMCs (Beppu et al., 2004). This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.